mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.05 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.05 |
mRNA |
BRD-K78574327 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.05 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.06 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.06 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.06 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
0.06 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.06 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.07 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.07 |